Rgenix is a privately-held clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.

310 E 67th St, Suite 1-12‎ New York, NY
(646) 856-9261
Foster Gonsalves

Foster Gonsalves, Ph.D., M.P.H.

VP of Drug Development & Strategy

Foster currently heads translational development of Rgenix’s pipeline and leads the implementation of the biomarker and diagnostic strategy. He is also a key member of the corporate strategy team where he supports product and portfolio planning. Prior to joining Rgenix, Foster was a Management Consultant with the Life Sciences Practice of Navigant Consulting/Easton Associates where he served clients in the pharmaceutical, biotech, private equity and medical devices sectors.

As a consultant, Foster helped his clients address key issues in generating market forecasts and product valuation, portfolio optimization and life cycle management for both early stage and marketed products. Foster was previously a postdoctoral fellow at the NYU Cancer Institute where he was awarded the Kimmel Foundation Fellowship to study and develop novel modulators of the Wnt-signaling pathway. Foster received his Ph.D. in Molecular and Cell Biology from the University of California at Berkeley, an M.P.H in Health Policy and Management from Columbia University Mailman School of Public Health and a B.Sc. with Honors in Microbiology and Biochemistry from St. Xavier’s College, Mumbai, India.